Likewise, DL strongly inhibited cholinergic (AChE and BChE) and β-amyloid formation enzymes (BACE-1), thereby showing potential as an effective agent to control Alzheimer’s disease. This evidence concerns the gene BCHE and early-onset autosomal dominant Alzheimer disease.